by embracemarketing | Oct 24, 2022 | BLOG
In the first article in our Barriers and Biases in Pharma Research series, we looked at the role of cognitive biases and heuristics in simplifying complex choices to produce imperfect but ‘good enough’ decision–making. We might think there are times when ‘good enough’...
by embracemarketing | Apr 22, 2022 | BLOG
Behavioural economics has been an enduring force in market research for some time now. Why is this approach to economic analysis, which applies psychological insights from individual behaviour, sustaining its relevance? Whilst technology advances, we’re all...
by embracemarketing | Dec 13, 2021 | BLOG
Rheumatoid disorders ranging from Rheumatoid Arthritis (RA) and Psoriatic Arthritis (PsA) to ankylosing spondylitis (AS) have seen huge therapeutic advancements over the last decade. From the release of the groundbreaking anti-TNF products, through to the...
by embracemarketing | Nov 9, 2021 | BLOG
Did you attend Reuters Pharma Europe 2021 which took place virtually on 11 – 22 October? Our team did and they captured some interesting takeaways on the hottest themes and key case studies. Here are their top 6 highlights from the conference: ...
by embracemarketing | Oct 28, 2021 | BLOG
Last year there were 2.3 million females diagnosed with breast cancer. It’s the world’s most prevalent cancer, and at Adelphi Research we’ve conducted many projects in this important space which have given us an opportunity to build up a breadth of knowledge and...
by embracemarketing | Jun 22, 2021 | BLOG
Telehealth has been a growing sector, even prior to COVID with roughly one quarter of physicians conducting telehealth visits and remote monitoring in 2019. But, how has the pandemic accelerated the widespread adoption of telehealth by consumers and is it here to...
Recent Comments